Revolution of Drug Eluting Coronary Stents: An Analysis of Market Leader
Percutaneous coronary intervention with drug-eluting stents (DES) is a well-established and widelyaccepted treatment approach in patients with coronary artery disease. Although the underlying principle of DES remains constant for different stents available on the market, certain factors may offer va...
Main Authors: | Ashok S. Thakkar, Bhargav A. Dave |
---|---|
Format: | Article |
Language: | English |
Published: |
European Medical Journal
2016-12-01
|
Series: | European Medical Journal |
Subjects: | |
Online Access: | https://emj.emg-health.com/wp-content/uploads/sites/2/2016/12/Revolution-of-Drug-Eluting-Coronary-Stents-An-Analysis-of-Market-Leader.pdf |
Similar Items
-
Bioresorbable Scaffolds: The Revolution in Coronary Stenting?
by: Lorenzo Azzalini, et al.
Published: (2016-03-01) -
Safety and efficacy of the Yukon Choice Flex sirolimus-eluting coronary stent in an all-comers population cohort
by: E. Xhepa, et al.
Published: (2014-05-01) -
One-Year Results of the Use of Absorb Bioresorbable Vascular Scaffold in Patients with Different Forms of Coronary Artery Disease as Compared to a Drug-Eluting Stent
by: Nabijon P. Yuldashev, et al.
Published: (2018-03-01) -
Bioresorbable vascular stents and drug-eluting stents in treatment of coronary heart disease: a meta-analysis
by: Le Ni, et al.
Published: (2020-01-01) -
Bioresorbable Drug-Eluting Magnesium-Alloy Scaffold for Treatment of Coronary Artery Disease
by: Carlos M. Campos, et al.
Published: (2013-12-01)